As of 2025-11-19, the Relative Valuation of Medmix Ltd (MEDX.SW) is (1.85) CHF. This relative valuation is based on P/E multiples. With the latest stock price at 8.53 CHF, the upside of Medmix Ltd based on Relative Valuation is -121.7%.
The range of the Relative Valuation is (3.32) - 0.14 CHF.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.5x - 31.9x | 28.2x |
| Forward P/E multiples | 33.1x - 35.6x | 34.4x |
| Fair Price | (3.32) - 0.14 | (1.85) |
| Upside | -139.0% - -98.4% | -121.7% |
| Date | P/E |
| 2025-11-14 | -64.32 |
| 2025-11-13 | -64.62 |
| 2025-11-12 | -64.91 |
| 2025-11-11 | -64.25 |
| 2025-11-10 | -63.44 |
| 2025-11-07 | -62.77 |
| 2025-11-06 | -63.29 |
| 2025-11-05 | -63.73 |
| 2025-11-04 | -64.47 |
| 2025-11-03 | -66.31 |
| 2025-10-31 | -67.93 |
| 2025-10-30 | -68.01 |
| 2025-10-29 | -68.37 |
| 2025-10-28 | -68.37 |
| 2025-10-27 | -71.25 |
| 2025-10-24 | -72.57 |
| 2025-10-23 | -72.65 |
| 2025-10-22 | -70.36 |
| 2025-10-21 | -68.15 |
| 2025-10-20 | -67.93 |
| 2025-10-17 | -68.08 |
| 2025-10-16 | -66.97 |
| 2025-10-15 | -64.91 |
| 2025-10-14 | -64.54 |
| 2025-10-13 | -65.35 |
| 2025-10-10 | -64.47 |
| 2025-10-09 | -65.43 |
| 2025-10-08 | -66.61 |
| 2025-10-07 | -64.17 |
| 2025-10-06 | -64.47 |
| 2025-10-03 | -65.13 |
| 2025-10-02 | -64.84 |
| 2025-10-01 | -64.84 |
| 2025-09-30 | -65.87 |
| 2025-09-29 | -66.31 |
| 2025-09-26 | -65.13 |
| 2025-09-25 | -68.15 |
| 2025-09-24 | -71.03 |
| 2025-09-23 | -73.83 |
| 2025-09-22 | -72.57 |
| 2025-09-19 | -72.79 |
| 2025-09-18 | -74.12 |
| 2025-09-17 | -74.42 |
| 2025-09-16 | -74.27 |
| 2025-09-15 | -74.71 |
| 2025-09-12 | -73.97 |
| 2025-09-11 | -74.71 |
| 2025-09-10 | -74.12 |
| 2025-09-09 | -74.86 |
| 2025-09-08 | -77.51 |